IHS Chemical Week

World News and Views :: Top of the News

Lonza Expands, Revamps Former Cambrex Site at Hopkinton, MA (update)

8:15 AM MDT | April 23, 2009 | Alex Scott

Lonza, one of the world’s most successful contract fine chemical companies, says it has completed the build out of a new mid-scale volume biologic drugs manufacturing facility at Hopkinton, MA. In parallel, Lonza says it has also revamped the entire Hopkinton site-formerly owned by Cambrex-to enhance infrastructure reliability including electricity and waste streams, and increase operational efficiency while meeting cGMP requirements. The new facility, a 2,000-liter microbial fermentation plant, is complemented by a highly flexible purification area capable...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa